The Annual Meeting is an extraordinary venue that fosters scientific discussions and helps build bridges across various disciplines. We always encourage all Annual Meeting attendees to capitalize on the opportunities during the meeting to learn about the latest breakthroughs in chemistry in cancer research, and network with other scientists and clinicians interested in the field, as well as to attend sessions outside your own areas of expertise.
The AACR Annual Meeting 2013 was held in Washington, D.C.
CICR hosted a variety of sessions and events at the Annual Meeting:
CICR Town Meeting and Networking Reception
Sunday, April 7, 2013
6:00 p.m. - 7:30 p.m.
Renaissance Hotel, Grand Ballroom Central
Chairperson: Billy W. Day, Ph.D., University of Pittsburgh School of Pharmacy
Chairperson-Elect: Michael J. Luzzio, Ph.D., Novartis Institutes for Biomedical Research
The Chemistry in Cancer Research Working Group (CICR) brought together 64 cancer-focused scientists in chemistry and chemistry-related fields to discuss the present status and future promise of chemistry in the advancement of the prevention and cure of cancer. All CICR members were encouraged to attend and all interested Annual Meeting registrants were also invited. This event provided an opportunity to raise questions and contribute ideas to help shape future CICR initiatives. Attendees also learned about membership in CICR, met the members of the Steering Committee, and connected with colleagues. A networking reception followed.
Other CICR-Related Content
Current Concepts in Diagnostics and Therapeutics
Nanotechnology Approaches to the Treatment of Cancer
Sunday, April 7, 2013, 1:00 p.m. - 3:00 p.m.; Room 152
Novel Therapeutic Concepts with Kinases, Immuno-, and Radiotherapy
Wednesday, April 10, 2013, 11:00 a.m. - 1:00 p.m.; Room 147
Antibody-Drug Conjugates Come of Age
Wednesday, April 10, 2013, 11:00 a.m. - 1:00 p.m.; Room 150
Special Sessions
New Drugs on the Horizon 1
Sunday, April 7, 2013, 1:00 p.m. - 3:00 p.m.; Room 207
New Drugs on the Horizon 2
Sunday, April 7, 2013, 3:15 p.m. - 5:15 p.m.; Room 207
Educational Sessions
From Chemistry to the Clinic: Pathways for Drug Discovery and Development Part 1: Targeting Mechanisms of Therapeutic Resistance
Saturday, April 6, 2013, 8:00 a.m. - 10:00 a.m.; Room 207
From Chemistry to the Clinic: Pathways for Drug Discovery and Development Part 2: Targeting Epigenetics: An Epicenter of Oncology Drug Discovery?
Saturday, April 6, 2013, 10:15 a.m. - 12:15 p.m.; Room 207
New Paradigms in Molecular Pharmacology
Saturday, April 6, 2013, 10:15 a.m. - 12:15 p.m.; Room 151
Therapeutic Nanotechnology
Saturday, April 6, 2013, 10:15 a.m. - 12:15 p.m.; Room 144
From Chemistry to the Clinic: Pathways for Drug Discovery and Development Part 3: Drug Lead Optimization
Saturday, April 6, 2013, 1:00 p.m. - 3:00 p.m.; Room 207
From Chemistry to the Clinic: Pathways for Drug Discovery and Development Part 4: Oncology Drug Discovery and Development: Combination Therapies
Saturday, April 6, 2013, 3:15 p.m. - 5:15 p.m.; Room 207
Rational Combination Therapies in Cancer
Saturday, April 6, 2013, 3:15 p.m. - 5:15 p.m.; Ballroom C
Fora
Human Variation and Its Impact on Drug Development
Monday, April 8, 2013, 5:00 p.m. - 6:30 p.m.; Room 145
Drug Discovery in Industry, Academia and Government: What Is the Track Record?
Tuesday, April 9, 2013, 5:00 p.m. - 6:30 p.m.; Room 202
Major Symposia
Expanding the Druggable Genome
Monday, April 8, 2013, 1:00 p.m. - 3:00 p.m.; Room 202
Intrinsic and Microenvironment-Dependent Adaptive Responses that Regulate Drug Resistance
Tuesday, April 9, 2013; 8:15 a.m. - 10:15 a.m.; Ballroom C
Target Validation by Chemical Probes/Designer Chemical Probes and Phenotypic Approach to Drug Discovery
Tuesday, April 9, 2013, 8:15 a.m. - 10:15 a.m.; Salon A-B, East Hall
Strategies to Overcoming Drug Resistance
Tuesday, April 9, 2013, 10:30 a.m. - 12:30 p.m.; Ballroom A-B
New Approaches to Drug Discovery
Tuesday, April 9, 2013, 10:30 a.m. - 12:30 p.m.; Room 146
Minisymposia
Chemical Modulation of Gene Expression
Sunday, April 7, 2013, 3:15 p.m. - 5:15 p.m.; Room 103
Identification of New Cancer Targets 1
Sunday, April 7, 2013, 3:15 p.m. - 5:15 p.m.; Room 150
Drug Discovery and Lead Optimization
Monday, April 8, 2013, 3:00 p.m. - 5:00 p.m.; Room 145
Novel Approaches to Targeting Critical Signaling Pathways
Monday, April 8, 2013, 3:00 p.m. - 5:00 p.m.; Room 150
Targeting the Mutated Ras/Raf/MEK Pathways in Melanoma
Monday, April 8, 2013, 3:00 p.m. - 5:00 p.m.; Room 151
Novel Targeted Therapies 2
Tuesday, April 9, 2013, 3:00 p.m. - 5:00 p.m.; Room 152
Mechanisms of Resistance to Targeted Therapies
Tuesday, April 9, 2013, 3:00 p.m. - 5:00 p.m.; Room 202
Poster Sessions
Chemical Biology
Monday, April 8, 2013, 1:00 p.m. - 5:00 p.m.; Hall A-C, Poster Section 43
Natural Products
Monday, April 8, 2013, 1:00 p.m. - 5:00 p.m.; Hall A-C, Poster Section 44
Drug Lead Optimization
Tuesday, April 9, 2013, 8:00 a.m. - 12:00 noon; Hall A-C, Poster Section 6
Proteomic and Metabolomic Applications for Cancer Research
Tuesday, April 9, 2013, 8:00 a.m. - 12:00 noon; Hall A-C, Poster Section 7
Drug Delivery Technology
Tuesday, April 9, 2013, 1:00 p.m. - 5:00 p.m.; Hall A-C, Poster Section 43
Imaging and Screening
Tuesday, April 9, 2013, 1:00 p.m. - 5:00 p.m.; Hall A-C, Poster Section 44
Drug Identification and Delivery
Wednesday, April 10, 2013, 8:00 a.m. - 12:00 noon; Hall A-C, Poster Section 44